Header
Header
Article

New patent for Teva Pharm drug AIRDUO RESPICLICK – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK


Annual Drug Patent Expirations for AIRDUO+RESPICLICK

Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are sixteen patents protecting this drug.

Drug patent litigation for AIRDUO RESPICLICK.

The generic ingredient in AIRDUO RESPICLICK is fluticasone propionate; salmeterol xinafoate. Four suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK



Source link

Back to top button